The Council has adopted the ‘pharma package’, a new set of rules that will increase patients’ access to medicine and make the EU’s pharmaceutical sector fairer and more competitive.
The package represents a far-reaching reform of the EU’s pharmaceutical legislation and will help ensure fair access to safe, effective and affordable medicines across the EU.
It also seeks to boost the competitiveness of the pharmaceutical industry by cutting regulatory burdens and strengthening security of supply to prevent and manage shortages.